This is a 24-week randomized, double-blind, parallel-group, multi-center, placebo-controlled study of tesaglitazar (0.5 and 1 mg) in patients with type…
Evaluation of Patient Satisfaction of Metered Dose Inhaler (MDI) With Counter in Asthmatics and Chronic Obstructive Pulmonary Disease Patients (COPD) medical clinical research trials
A Pivotal, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety of TAK-242 in Adults With Severe Sepsis clinical research trials